Richard J Drew
Overview
Explore the profile of Richard J Drew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armstrong S, Brady J, Drew R, Foran A
Pediatr Res
. 2024 Oct;
PMID: 39455860
Background: Procalcitonin-guided antimicrobial decision-making has been shown to be safe in adult intensive care settings. Most antimicrobial exposure in neonatal units is in culture-negative conditions. We hypothesise that Procalcitonin aids...
2.
OReilly D, Livada A, Steiner L, Drew R, Mc Callion N
Pediatr Res
. 2024 Aug;
96(6):1459-1463.
PMID: 39215199
A "one health" approach recognises that human health, animal health and planetary health are closely interlinked and that a transdisciplinary approach is required to fully understand and maintain global health....
3.
Brouwer L, Cunney R, Drew R
Eur J Pediatr
. 2024 Apr;
183(7):2983-2993.
PMID: 38634890
Early recognition of bloodstream infection (BSI) in infants can be difficult, as symptoms may be non-specific, and culture can take up to 48 h. As a result, many infants receive...
4.
Drew R, Eogan M
Int J Gynaecol Obstet
. 2024 Mar;
166(1):27-34.
PMID: 38491782
Background: Mycoplasma genitalium is an emerging pathogen, which has been linked to cervicitis, urethritis and pelvic inflammatory disease (PID). With the advent of multiplex polymerase chain reaction (PCR) panels for...
5.
Kadambari S, Feng S, Liu X, Andersson M, Waterfield R, Fodder H, et al.
Pediatr Infect Dis J
. 2024 Jan;
43(4):345-349.
PMID: 38190645
Background: Multiplex polymerase chain reaction assays have the potential to reduce antibiotic use and shorten length of inpatient stay in children with suspected central nervous system infection by obtaining an...
6.
Giva S, Barry R, Drew R, Geoghegan S
Pediatr Infect Dis J
. 2023 Aug;
42(12):1031-1034.
PMID: 37589456
Background: Human nonpolio enterovirus (EV) is a major cause of infection in neonates and infants; however, the clinical presentation and cerebrospinal fluid findings vary significantly. Infection caused by EV in...
7.
Houlihan E, Barry R, Knowles S, Eogan M, Drew R
Eur J Obstet Gynecol Reprod Biol
. 2023 Jul;
288:130-134.
PMID: 37515907
Background: Current national guidance in Ireland states that asymptomatic bacteriuria (AB) should be screened for at 12-16 weeks' gestation and treated with a seven-day course of antimicrobials, due to the...
8.
Barry R, Houlihan E, Knowles S, Eogan M, Drew R
Eur J Clin Microbiol Infect Dis
. 2023 May;
42(7):827-833.
PMID: 37126130
Pyelonephritis affects 1-2% of pregnant women, and is associated with significant maternal and fetal morbidity. Antenatal pyelonephritis has been associated with PPROM (preterm premature rupture of membranes), preterm labour, low...
9.
Gonzales-Luna A, Skinner A, Alonso C, Bouza E, Cornely O, de Meij T, et al.
Lancet Infect Dis
. 2023 Apr;
23(7):e259-e265.
PMID: 37062301
With the approval and development of narrow-spectrum antibiotics for the treatment of Clostridioides difficile infection (CDI), the primary endpoint for treatment success of CDI antibiotic treatment trials has shifted from...
10.
Geoghegan S, Faerber J, Stephens L, Gillan H, Drew R, Eogan M, et al.
Hum Vaccin Immunother
. 2023 Apr;
19(1):2195331.
PMID: 37036198
Group B (GBS) vaccines, designed to be given to pregnant women, are in clinical trials. There is an opportunity to conduct preparatory research now to understand the drivers of and...